Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Trial to Evaluate the Safety, Tolerability, PK, and Preliminary Efficacy of Single and Multiple Ascending Doses of YN001 in Healthy Subjects and Multiple Ascending Doses of YN001 in Patient With Coronary Atherosclerosis

NCT06048588 is registered in ClinicalTrials.gov with Beijing Inno Medicine Co., Ltd. as lead sponsor.

NCT NCT06048588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06048588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Trial to Evaluate the Safety, Tolerability, PK, and Preliminary Efficacy of Single and Multiple Ascending Doses of YN001 in Healthy Subjects and Multiple Ascending Doses of YN001 in Patient With Coronary Atherosclerosis
Lead sponsor
Beijing Inno Medicine Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
October 8, 2023
Completion date
April 27, 2025
Enrollment
144 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease